Artificial Intelligence (AI) in Drug Discovery Market Size, Share & COVID-19 Impact Analysis, By Drug Type (Small Molecule and Large Molecule), By Offering (Software and Services), By Technology (Machine Learning, Natural Language Processing, and Others), By Application (Endocrinology, Cardiology, Oncology, Neurology, and Others), By End-user (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2023-2030

ATTRIBUTE

DETAILS

Study Period

2017-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2017-2021

Growth Rate

CAGR of 12.2% from 2023 to 2030

Unit

Value (USD Billion)

Segmentation

By Drug Type, Offering, Technology, Application, End-user, and Region

By Drug Type

• Small Molecule
• Large Molecule

By Offering

• Software
• Services

By Technology

• Machine Learning
• Natural Language Processing
• Others

By Application

• Endocrinology
• Cardiology
• Oncology
• Neurology
• Others

By End-user

• Pharmaceutical & Biotechnological Companies
• Academic & Research Institutes
• Others

By Region

• North America (By Drug Type, Offering, Technology, Application, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Drug Type, Offering, Technology, Application, End-user, and Country/Sub-Region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Drug Type, Offering, Technology, Application, End-user, and Country/Sub-Region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Drug Type, Offering, Technology, Application, End-user, and Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Drug Type, Offering, Technology, Application, End-user, and Country/Sub-Region)
  • GCC
  • South Africa
• Rest of the Middle East & Africa